Cargando…
Public research funding and pharmaceutical prices: do Americans pay twice for drugs?
In the debate over prescription drug pricing, some pharmaceutical industry critics claim that U.S. taxpayers pay twice for costly therapies, because publicly supported research is a major contributor to drug discovery and American taxpayers are inadequately rewarded for their research investment due...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642989/ https://www.ncbi.nlm.nih.gov/pubmed/33204410 http://dx.doi.org/10.12688/f1000research.24934.1 |